Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sauerberg

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonistsA Christopoulos, M K Grant, N Ayoubzadeh, et al.
Chirality|January 1, 1997
Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane typeP H Olesen, P Sauerberg, T G Petersen, et al.
Biochemical and Biophysical Research Communications|October 10, 1992
Steric and electronic requirements for muscarinic receptor-stimulated phosphoinositide turnover in the CNS in a series of arecoline bioisosteresD Ngur, S Roknich, C H Mitch, et al.
Journal of Medicinal Chemistry|June 12, 1992
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines P Sauerberg, P H Olesen, S Nielsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
Schizophrenia Research|April 29, 2000
Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
Dementia (Basel, Switzerland)|July 1, 1996
PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and manL Farde, T Suhara, C Halldin, et al.
Biochemical and Biophysical Research Communications|March 26, 1998
Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cellsN DeLapp, S Wu, R Belagaje, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Synthesis and pharmacological evaluation of dimeric muscarinic acetylcholine receptor agonistsA Christopoulos, M K Grant, N Ayoubzadeh, et al.
Chirality|January 1, 1997
Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane typeP H Olesen, P Sauerberg, T G Petersen, et al.
Biochemical and Biophysical Research Communications|October 10, 1992
Steric and electronic requirements for muscarinic receptor-stimulated phosphoinositide turnover in the CNS in a series of arecoline bioisosteresD Ngur, S Roknich, C H Mitch, et al.
Journal of Medicinal Chemistry|June 12, 1992
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines P Sauerberg, P H Olesen, S Nielsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
Schizophrenia Research|April 29, 2000
Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
Dementia (Basel, Switzerland)|July 1, 1996
PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and manL Farde, T Suhara, C Halldin, et al.
Biochemical and Biophysical Research Communications|March 26, 1998
Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cellsN DeLapp, S Wu, R Belagaje, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Pageof 4